PGIM e-Repository

Survival Benefit, Toxic Profile, Cost Effectiveness in Patients Treated with 5 Fluoropyrimidine and Capecitabine for Colorectal Cancer in Adjuvant Setting

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account